Pharmaniaga Berhad (KLSE:PHARMA)

Pharmaniaga Berhad Cash Flow Statement

Financials in millions MYR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	43.16	131.82	-80.16	-629.92	172.15	27.49
Depreciation & Amortization	32.98	38.35	38.77	34.02	31.7	30.76
Other Amortization	7.24	3.03	2.93	2.41	1.68	1.58
Other Operating Activities	-92.4	-130.53	85.41	451.15	-269.58	-85.54
Operating Cash Flow	-9.02	42.67	46.95	-142.34	-64.06	-25.71
Operating Cash Flow Growth	-	-9.12%	-	-	-	-
Capital Expenditures	-30.28	-31.16	-50.67	-59.26	-30.39	-9.25
Sale of Property, Plant & Equipment	0.28	0.08	1.32	0.06	0.21	0
Sale (Purchase) of Intangibles	-5.71	-8.41	-10.34	-18.38	-14.97	-23.38
Other Investing Activities	-158.23	-6.13	-8.24	5.25	-0.41	-
Investing Cash Flow	-193.94	-45.62	-67.93	-72.34	-45.56	-32.64
Short-Term Debt Issued	-	-	50	-	-	-
Long-Term Debt Issued	-	2,150	3,248	2,291	2,329	1,541
Total Debt Issued	2,115	2,150	3,298	2,291	2,329	1,541
Long-Term Debt Repaid	-	-2,139	-3,240	-1,988	-2,149	-1,443
Total Debt Repaid	-2,367	-2,139	-3,240	-1,988	-2,149	-1,443
Net Debt Issued (Repaid)	-251.78	10.67	57.48	303.42	179.73	97.72
Issuance of Common Stock	569.57	-	45.86	-	-	-
Common Dividends Paid	-	-	-7.86	-82.53	-58.95	-26.14
Other Financing Activities	5.31	11.43	-0.21	-0.1	-0.04	-0.09
Financing Cash Flow	323.1	22.1	95.27	220.79	120.74	71.49
Foreign Exchange Rate Adjustments	-0.57	-0.52	0.31	-0.39	0.13	-0.23
Net Cash Flow	119.57	18.64	74.59	5.74	11.25	12.91
Free Cash Flow	-39.31	11.51	-3.72	-201.6	-94.44	-34.96
Free Cash Flow Margin	-1.00%	0.31%	-0.11%	-5.79%	-1.96%	-1.28%
Free Cash Flow Per Share	-0.02	0.01	-0.00	-0.15	-0.07	-0.03
Cash Interest Paid	63.86	68.11	60.81	41.29	32.63	38.57
Cash Income Tax Paid	52.11	33.89	20.56	39.52	39.7	2.94
Levered Free Cash Flow	-62	-16.53	31.75	479.12	-143.76	-75.73
Unlevered Free Cash Flow	-19.93	28.45	70.4	504.15	-122.93	-54.67

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.